Precision medicine in rheumatoid arthritis: advances and clinical applications of multi-omics biomarkers
This paper analyzes the challenges faced by multi-omics biomarkers during clinical translation, including technical barriers, cost-effectiveness, and standardization, and critically evaluates the nascent integration of spatialomics and liquid biopsy technologies within the “multi-omics + AI” framework.